A detailed history of Man Group PLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Man Group PLC holds 75,319 shares of UTHR stock, worth $30.2 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
75,319
Previous 106,521 29.29%
Holding current value
$30.2 Million
Previous $24.5 Million 1.95%
% of portfolio
0.06%
Previous 0.06%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$228.26 - $319.04 $7.12 Million - $9.95 Million
-31,202 Reduced 29.29%
75,319 $24 Million
Q1 2024

May 15, 2024

BUY
$210.76 - $249.51 $15.1 Million - $17.9 Million
71,681 Added 205.74%
106,521 $24.5 Million
Q4 2023

Feb 14, 2024

SELL
$214.88 - $256.94 $5.33 Million - $6.37 Million
-24,798 Reduced 41.58%
34,840 $7.66 Million
Q3 2023

Nov 14, 2023

BUY
$211.82 - $248.24 $9.43 Million - $11.1 Million
44,527 Added 294.67%
59,638 $13.5 Million
Q2 2023

Aug 14, 2023

SELL
$205.19 - $232.99 $15.5 Million - $17.6 Million
-75,565 Reduced 83.34%
15,111 $3.34 Million
Q1 2023

May 15, 2023

SELL
$212.99 - $276.17 $130,562 - $169,292
-613 Reduced 0.67%
90,676 $20.3 Million
Q4 2022

Feb 14, 2023

SELL
$205.95 - $280.43 $6.7 Million - $9.12 Million
-32,526 Reduced 26.27%
91,289 $25.4 Million
Q3 2022

Nov 14, 2022

SELL
$203.3 - $244.17 $773,556 - $929,066
-3,805 Reduced 2.98%
123,815 $25.9 Million
Q2 2022

Aug 15, 2022

BUY
$174.81 - $241.14 $10.5 Million - $14.4 Million
59,884 Added 88.41%
127,620 $30.1 Million
Q1 2022

May 16, 2022

BUY
$166.16 - $213.96 $1.17 Million - $1.5 Million
7,026 Added 11.57%
67,736 $12.2 Million
Q4 2021

Feb 14, 2022

BUY
$184.32 - $216.08 $7.11 Million - $8.34 Million
38,600 Added 174.58%
60,710 $13.1 Million
Q3 2021

Nov 15, 2021

SELL
$179.86 - $214.88 $5.21 Million - $6.23 Million
-28,991 Reduced 56.73%
22,110 $4.08 Million
Q2 2021

Aug 16, 2021

SELL
$170.47 - $211.93 $5.6 Million - $6.96 Million
-32,856 Reduced 39.13%
51,101 $9.17 Million
Q1 2021

May 17, 2021

SELL
$153.94 - $174.85 $2.97 Million - $3.38 Million
-19,319 Reduced 18.71%
83,957 $14 Million
Q4 2020

Feb 16, 2021

BUY
$101.87 - $151.79 $9.46 Million - $14.1 Million
92,908 Added 896.1%
103,276 $15.7 Million
Q3 2020

Nov 16, 2020

SELL
$99.9 - $121.13 $4.37 Million - $5.3 Million
-43,757 Reduced 80.84%
10,368 $1.05 Million
Q2 2020

Aug 14, 2020

BUY
$92.74 - $125.82 $4.77 Million - $6.47 Million
51,414 Added 1896.5%
54,125 $6.55 Million
Q1 2020

May 15, 2020

BUY
$79.39 - $115.35 $215,226 - $312,713
2,711 New
2,711 $257,000
Q3 2019

Nov 14, 2019

SELL
$74.85 - $85.99 $1.04 Million - $1.19 Million
-13,891 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$76.06 - $120.81 $1.7 Million - $2.7 Million
-22,330 Reduced 61.65%
13,891 $1.08 Million
Q1 2019

May 15, 2019

SELL
$107.15 - $126.84 $3.23 Million - $3.82 Million
-30,100 Reduced 45.39%
36,221 $4.25 Million
Q4 2018

Feb 14, 2019

SELL
$101.4 - $128.73 $930,446 - $1.18 Million
-9,176 Reduced 12.15%
66,321 $7.22 Million
Q3 2018

Nov 14, 2018

BUY
$113.81 - $129.46 $3.29 Million - $3.74 Million
28,918 Added 62.08%
75,497 $9.65 Million
Q2 2018

Aug 14, 2018

BUY
$101.14 - $118.31 $1.29 Million - $1.51 Million
12,771 Added 37.78%
46,579 $5.27 Million
Q1 2018

May 15, 2018

BUY
$107.21 - $151.94 $3.62 Million - $5.14 Million
33,808 New
33,808 $3.8 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $18.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.